Assessing The Diagnostic Accuracy of BIRADS Score Versus Histopathological Findings in Clinically Palpable Breast Lumps: A Comparative Study

Abstract

Introduction: Breast Imaging Reporting and Data System (BIRADS) scores are widely used in clinical practice to assess breast lesions detected through imaging. This study aims to compare the diagnostic accuracy of BIRADS scores with histopathological findings in clinically palpable breast lumps.

Aims and Objectives: To compare the diagnostic accuracy of BI-RADS score in detecting Malignant lesions with histopathological findings

Methods: A study was conducted on 100 female patients presenting with clinically palpable breast lumps at the Department of General Surgery of MKCG Medical College. The patients were classified according to BI-RADS categories 2, 3, 4a, 4b, 4c, or 5 based on radiological examinations. The correlation between BI-RADS classification and histopathological results was evaluated using descriptive statistics. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy were calculated to assess the diagnostic performance of BI-RADS scores.

Results: A total of 100 patients with clinically palpable breast lumps were included in the study. Considering histopathological examination as the gold standard, the sensitivity and specificity of BI-RADS score is 93.9% and 82.3% respectively. The BI-RADS score has a positive predictive value of 91.1%, a negative predictive value of 87.5%, and a diagnostic accuracy of 90.0%, respectively.

Conclusions: This comparative study reveals that while BIRADS scores provide valuable information for the assessment of clinically palpable breast lumps, their diagnostic accuracy varies. BI-RADS score being non-invasive, it may become a very useful test for evaluating Breast lump lesions but cannot be considered as gold standard and thus cannot be used as an alternative to histopathology in diagnosis of breast lumps.